The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 26 | — | 20.1x | Below average | |
Growth | 84 | 79.9% | 5.6% | Above average | |
Quality | 45 | 6.6% | 7.6% | Near average | |
Safety | 67 | -0.7x | 0.4x | Near average | |
Capital Return | 80 | — | 2.19% | Above average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Eton Pharmaceuticals, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Eton Pharmaceuticals, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
ETON stock shows complete stability in its target price at 57 dollars over the past 7 and 30-day periods, with a total absence of Dispersion among analysts, as the high and low estimates align with the average. This consistency reflects a unified view by the sole analyst currently covering the stock, indicating a stable conviction in the fair value of the stock despite the significant price gap from the current price of 32.59 dollars.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.